SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: FEBRUARY 13, 2001
(Date of earliest event reported)
INCYTE GENOMICS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-27488 94-3136539
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
3160 PORTER DRIVE, PALO ALTO, CALIFORNIA 94304
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (650) 855-0555
Item 5. Other Events.
-------------
Attached hereto as Exhibit 99.1 and incorporated by reference herein is
financial information for Incyte Genomics, Inc. for the quarter and year ended
December 31, 2000.
Item 7. Financial Statements and Exhibits.
------------------------------------
(a) Exhibits.
99.1 Incyte Genomics, Inc. Financial Results for the Quarter and Year Ended
December 31, 2000.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 13, 2001.
INCYTE GENOMICS, INC.
By /s/ John M. Vuko
-------------------
John M. Vuko
Executive Vice President and
Chief Financial Officer
INDEX TO EXHIBITS
Exhibit Number Description
--------------
99.1 . . . . . Incyte Genomics, Inc. Financial Results for the Quarter and
Year Ended December 31, 2000.